vs
Rumble Inc.（RUM）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Rumble Inc.的1.3倍（$35.5M vs $27.1M），Rumble Inc.净利率更高（-120.8% vs -304.2%，领先183.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -10.5%），Rumble Inc.自由现金流更多（$-31.7M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 15.2%）
Rumble Inc.是一家加美跨国企业，主营在线视频平台、网络托管及云服务，总部位于加拿大多伦多，美国总部设在佛罗里达州朗博特基。公司由加拿大科技创业者克里斯·帕夫洛夫斯基于2013年创立，云服务板块为Truth Social提供托管支持，其视频平台在美国保守派及极右翼用户群体中广受欢迎，属于“另类科技”阵营。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
RUM vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $27.1M | $35.5M |
| 净利润 | $-32.7M | $-108.1M |
| 毛利率 | 5.5% | 59.8% |
| 营业利润率 | -131.1% | -304.8% |
| 净利率 | -120.8% | -304.2% |
| 营收同比 | -10.5% | 681.7% |
| 净利润同比 | 86.2% | 39.6% |
| 每股收益（稀释后） | $-0.13 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $27.1M | $35.5M | ||
| Q3 25 | $24.8M | $5.2M | ||
| Q2 25 | — | $19.2M | ||
| Q1 25 | $23.7M | $14.7M | ||
| Q4 24 | $30.2M | $4.5M | ||
| Q3 24 | $25.1M | $26.1M | ||
| Q2 24 | $22.5M | $14.4M | ||
| Q1 24 | $17.7M | $13.8M |
| Q4 25 | $-32.7M | $-108.1M | ||
| Q3 25 | $-16.3M | $-162.3M | ||
| Q2 25 | — | $-171.9M | ||
| Q1 25 | $-2.7M | $-202.5M | ||
| Q4 24 | $-236.8M | $-178.9M | ||
| Q3 24 | $-31.5M | $-95.8M | ||
| Q2 24 | $-26.8M | $-97.5M | ||
| Q1 24 | $-43.3M | $-91.4M |
| Q4 25 | 5.5% | 59.8% | ||
| Q3 25 | -1.8% | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | -26.7% | -48.0% | ||
| Q4 24 | -14.2% | -181.4% | ||
| Q3 24 | -45.4% | 53.7% | ||
| Q2 24 | -58.8% | 36.2% | ||
| Q1 24 | -79.5% | 19.1% |
| Q4 25 | -131.1% | -304.8% | ||
| Q3 25 | -113.6% | -3327.6% | ||
| Q2 25 | — | -916.8% | ||
| Q1 25 | -153.5% | -1297.9% | ||
| Q4 24 | -80.1% | -4042.4% | ||
| Q3 24 | -131.0% | -377.1% | ||
| Q2 24 | -172.7% | -697.4% | ||
| Q1 24 | -197.4% | -698.4% |
| Q4 25 | -120.8% | -304.2% | ||
| Q3 25 | -65.7% | -3135.3% | ||
| Q2 25 | — | -894.2% | ||
| Q1 25 | -11.2% | -1373.3% | ||
| Q4 24 | -783.2% | -3935.5% | ||
| Q3 24 | -125.9% | -367.5% | ||
| Q2 24 | -119.2% | -676.6% | ||
| Q1 24 | -244.1% | -662.4% |
| Q4 25 | $-0.13 | $-0.17 | ||
| Q3 25 | $-0.06 | $-0.36 | ||
| Q2 25 | — | $-0.41 | ||
| Q1 25 | $-0.01 | $-0.50 | ||
| Q4 24 | $-1.17 | $-0.56 | ||
| Q3 24 | $-0.15 | $-0.34 | ||
| Q2 24 | $-0.13 | $-0.40 | ||
| Q1 24 | $-0.21 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $237.9M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $274.8M | $1.1B |
| 总资产 | $336.8M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $237.9M | $743.3M | ||
| Q3 25 | $269.8M | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | $301.3M | $500.5M | ||
| Q4 24 | $114.0M | $594.4M | ||
| Q3 24 | $132.0M | $427.6M | ||
| Q2 24 | $154.2M | $474.3M | ||
| Q1 24 | $183.8M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $274.8M | $1.1B | ||
| Q3 25 | $302.2M | $1.0B | ||
| Q2 25 | — | $919.1M | ||
| Q1 25 | $339.6M | $933.9M | ||
| Q4 24 | $-63.1M | $1.0B | ||
| Q3 24 | $166.1M | $524.6M | ||
| Q2 24 | $192.7M | $584.4M | ||
| Q1 24 | $210.7M | $401.2M |
| Q4 25 | $336.8M | $1.5B | ||
| Q3 25 | $367.2M | $1.4B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | $391.1M | $1.3B | ||
| Q4 24 | $195.3M | $1.4B | ||
| Q3 24 | $217.2M | $726.5M | ||
| Q2 24 | $243.2M | $775.9M | ||
| Q1 24 | $263.0M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-31.7M | $-47.3M |
| 自由现金流率自由现金流/营收 | -117.2% | -133.1% |
| 资本支出强度资本支出/营收 | 8.5% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-70.8M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-29.4M | $-46.1M | ||
| Q3 25 | $-10.6M | $-117.4M | ||
| Q2 25 | — | $-76.4M | ||
| Q1 25 | $-14.5M | $-132.0M | ||
| Q4 24 | $-12.4M | $-115.4M | ||
| Q3 24 | $-19.1M | $-59.2M | ||
| Q2 24 | $-21.7M | $-82.2M | ||
| Q1 24 | $-33.9M | $-102.3M |
| Q4 25 | $-31.7M | $-47.3M | ||
| Q3 25 | $-12.0M | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | $-14.6M | $-133.8M | ||
| Q4 24 | $-12.4M | $-116.7M | ||
| Q3 24 | $-19.9M | $-63.8M | ||
| Q2 24 | $-23.1M | $-83.4M | ||
| Q1 24 | $-34.3M | $-109.0M |
| Q4 25 | -117.2% | -133.1% | ||
| Q3 25 | -48.6% | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | -61.7% | -907.4% | ||
| Q4 24 | -40.9% | -2567.7% | ||
| Q3 24 | -79.5% | -244.6% | ||
| Q2 24 | -102.8% | -578.5% | ||
| Q1 24 | -193.3% | -789.9% |
| Q4 25 | 8.5% | 3.5% | ||
| Q3 25 | 5.7% | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | 0.6% | 12.4% | ||
| Q4 24 | 0.1% | 28.6% | ||
| Q3 24 | 3.4% | 17.5% | ||
| Q2 24 | 6.1% | 8.2% | ||
| Q1 24 | 2.4% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |
RXRX
暂无分部数据
